Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y P Liu

Showing results (11-20 of 287) with videos related to

Pageof 29
Sort By:
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|June 4, 2020
[Clear cell renal cell carcinoma with thyroid metastases: report of three cases]Y Liu, Y P Liu
Biochimica Et Biophysica Acta|September 11, 1978
Protein activator of cyclic AMP phosphodiesterase and cyclic nucleotide phosphodiesterase in bovine retina and bovine lens. Activity, subcellular distribution and kinetic parametersY P Liu, H S Schwartz
Biochimica Et Biophysica Acta|March 22, 1979
A heat-stable protein inhibitor of cyclic 3',5'-nucleotide phosphodiesteraseY P Liu, V G Wong
The Science of the Total Environment|September 23, 2003
Modelling metal desorption kinetics in estuariesG E Millward, Y P Liu
Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association|March 1, 1976
The carboxyl- and amino-terminal amino acids and other properties of L-asparaginase from Escherichia coliY P Liu, R J Speer
The Journal of Biological Chemistry|January 10, 1972
Nitroasparaginase. Subunit cross-linkage and altered substrate specificityY P Liu, R E Handschumacher
The Journal of Automatic Chemistry|January 1, 1991
Refinement and evaluation of an automated mass spectrometer for nitrogen isotope analysis by the Rittenberg techniqueR L Mulvaney, Y P Liu
The Journal of Biological Chemistry|July 25, 1976
Cyclic 3':5'-nucleotide phosphodiesterase. Ca2+ confers more helical conformation to the protein activatorY P Liu, W Y Cheung
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1992
[Preparation and biological activities of monoclonal antibody-streptonigrin immunoconjugates]Y P Liu, J B Wu
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|December 8, 2025
[Hot issues after the release of the guideline for HER2 testing in breast cancer (2024 version)]Y P Liu, W T Yang
Pageof 29

Showing results (11-20 of 287) with videos related to

Sort By:
Pageof 29
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|June 4, 2020
[Clear cell renal cell carcinoma with thyroid metastases: report of three cases]Y Liu, Y P Liu
Biochimica Et Biophysica Acta|September 11, 1978
Protein activator of cyclic AMP phosphodiesterase and cyclic nucleotide phosphodiesterase in bovine retina and bovine lens. Activity, subcellular distribution and kinetic parametersY P Liu, H S Schwartz
Biochimica Et Biophysica Acta|March 22, 1979
A heat-stable protein inhibitor of cyclic 3',5'-nucleotide phosphodiesteraseY P Liu, V G Wong
The Science of the Total Environment|September 23, 2003
Modelling metal desorption kinetics in estuariesG E Millward, Y P Liu
Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association|March 1, 1976
The carboxyl- and amino-terminal amino acids and other properties of L-asparaginase from Escherichia coliY P Liu, R J Speer
The Journal of Biological Chemistry|January 10, 1972
Nitroasparaginase. Subunit cross-linkage and altered substrate specificityY P Liu, R E Handschumacher
The Journal of Automatic Chemistry|January 1, 1991
Refinement and evaluation of an automated mass spectrometer for nitrogen isotope analysis by the Rittenberg techniqueR L Mulvaney, Y P Liu
The Journal of Biological Chemistry|July 25, 1976
Cyclic 3':5'-nucleotide phosphodiesterase. Ca2+ confers more helical conformation to the protein activatorY P Liu, W Y Cheung
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1992
[Preparation and biological activities of monoclonal antibody-streptonigrin immunoconjugates]Y P Liu, J B Wu
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|December 8, 2025
[Hot issues after the release of the guideline for HER2 testing in breast cancer (2024 version)]Y P Liu, W T Yang
Pageof 29